Dr. Spyridon A. Mastroyannis, MD

  • Loveland, CO
  • Gynecologic oncologist
NPI1700272986PAC ID4880990142
Medicare services, 2024
229
Medicare patients, 2024
115
Part D claims, 2024
170
Publications
25
Hospital affiliations
6
Practice address
2695 Rocky Mountain Ave, Loveland, CO 80538
Practice phone
Call (970) 203-7050
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

UCHealth Medical Group

Loveland, Colorado

See all 10 affiliations

Find Dr. Mastroyannis' professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Spyridon A. Mastroyannis is a gynecologic oncologist in Loveland, Colorado

Dr. Mastroyannis practices at UCHealth Medical Group in Loveland, Colorado.

Dr. Mastroyannis' NPI, 1700272986, was assigned on April 14, 2015. Dr. Mastroyannis graduated from George Washington University School of Medicine in 2015. Dr. Mastroyannis holds Colorado license DR.0068092.

NPI and contact details
Medicare PAC ID
4880990142
NPI enumeration date
April 14, 2015
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(970) 203-7050
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
37
Medical school graduation
2015

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Spyridon A. Mastroyannis practices at UCHealth Medical Group in Loveland, Colorado

Dr. Mastroyannis' primary practice is UCHealth Medical Group, at 2695 Rocky Mountain Ave, Loveland, CO 80538 in Larimer County. The practice phone is (970) 203-7050.

  • UCHealth Medical Group
    2695 Rocky Mountain Ave, Loveland, CO 80538 · Larimer CountyPhone(970) 203-7050

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Spyridon A. Mastroyannis is affiliated with 8 sites of care and 2 medical groups

Dr. Mastroyannis' primary practice is UCHealth Medical Group in Loveland, Colorado. Dr. Mastroyannis is also affiliated with UCHealth Medical Center of the Rockies. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Mastroyannis to 5 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

See all 10 affiliations for Dr. Mastroyannis

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Spyridon A. Mastroyannis' practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mastroyannis practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
UCHealth Medical GroupAvailable with a free account
+7 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Mastroyannis practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Spyridon A. Mastroyannis is one of 32 gynecologic oncologists in Colorado

Gynecologic oncology is Dr. Mastroyannis' primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Mastroyannis is licensed in Colorado.

Specialties and state licenses

  • Gynecologic oncology, ColoradoPrimaryLicense DR.0068092 · taxonomy 207VX0201X

Gynecologic oncologists near Dr. Mastroyannis

Counts of gynecologic oncologists with a Dmand AI profile, by place and practice. Each opens the list.

32gynecologic oncologists in Colorado
3gynecologic oncologists in Loveland

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Spyridon A. Mastroyannis billed Medicare for 229 services in 2024

CMS data shows 229 Medicare services from Dr. Mastroyannis across 8 procedure codes in 2024, for 115 Medicare patients. Medicare paid $31,695 for them.

Medicare services, 2024229
Medicare patients115
Paid by Medicare$31,695
Procedure codes8

Dr. Mastroyannis' Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1042024: 15650%
Other services
2023: 02024: 37
Surgery
2023: 122024: 36200%

Where Dr. Mastroyannis' Medicare services took place, 2024

  • In an office4419%
  • In a facility18581%

Dr. Mastroyannis compared with the Colorado median for gynecologic oncologists, 2024

  • Dr. Mastroyannis
  • Colorado median
Medicare services
229vs 16440% above
Medicare patients
115vs 9126% above
Part D claims
46vs 4015% above

Medians across 30 gynecologic oncologists in Colorado with Dmand AI profiles that report each measure.

Dr. Mastroyannis' most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Mastroyannis

Need commercial claims for Dr. Mastroyannis?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mastroyannis and other gynecologic oncologists in Colorado.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Spyridon A. Mastroyannis treated 115 Medicare patients in 2024, average age 73

CMS counts 115 Medicare patients who saw Dr. Mastroyannis in 2024. The largest group is 65 to 74, with 70 patients. 66% of them have high blood pressure, and 63% have cancer. 16% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mastroyannis' median patient age at 70, with 99% women.

Medicare patients, 2024115
Average age73
Average risk score1.85
Also on Medicaid16%

Dr. Mastroyannis' Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Chronic conditions among Dr. Mastroyannis' Medicare patients, 2024

  1. High blood pressure66%
  2. Cancer63%
  3. High cholesterol61%
  4. Arthritis38%
  5. Anxiety26%
  6. Ischemic heart disease25%
  7. Mood disorders25%
  8. Depression23%

Share of Medicare patients with each condition. A patient can have several.

Dr. Mastroyannis' patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women99%
  • Men1%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Spyridon A. Mastroyannis wrote 170 Medicare Part D claims in 2024

In 2024, Dr. Mastroyannis wrote 170 Medicare Part D claims for 57 patients. 71% of them were for generic drugs. CMS names the drug for 46 of them, across 2 drugs with 11 or more claims each, at $20,438 in total drug cost. In 2023, CMS named 58 claims across 4 drugs.

Part D claims, 2024170
Drugs named by CMS2
Total drug cost$20,438
Part D patients57

Dr. Mastroyannis' Part D claims by kind of drug, 2024

  • Generic120 claims71%
  • Brand-name50 claims29%

Dr. Mastroyannis' most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Mastroyannis' Part D claims, 2024

  • Opioids8%13 of 170 claims
  • Antibiotics12%20 of 170 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 582024: 4621%

Drugs named by CMS: 2 in 2024, 4 in 2023.

See all prescribing by Dr. Mastroyannis

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Spyridon A. Mastroyannis ranks in the 95th percentile for removal of the uterus in Medicare

Dr. Mastroyannis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mastroyannis as offering telehealth. CMS counts 26 procedures of removal of the uterus by Dr. Mastroyannis, more than 95% of the clinicians it reports for that procedure.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Where Dr. Mastroyannis ranks in Medicare procedure volume

Removal of the uterus
95th percentile26 procedures

CMS ranks each clinician against every clinician it reports for the same procedure category.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find gynecologic oncologists like Dr. Mastroyannis by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Spyridon A. Mastroyannis has 25 publications on record

Dmand AI links 25 papers to Dr. Mastroyannis, published from 2013 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Ovarian Neoplasms, Carcinoma, Ovarian Epithelial and Hysterectomy. Dr. Mastroyannis has published most often in Gynecol Oncol. Dr. Mastroyannis' most frequent co-authors are Dimitrios Nasioudis, MD, Emily M. Ko, MD and Lori Amanda Cory, MD.

Papers25
Years published2013 to 2025

Dr. Mastroyannis' papers by year, 2015 to 2025

Topics Dr. Mastroyannis writes about most

  • Ovarian Neoplasms
  • Carcinoma, Ovarian Epithelial
  • Hysterectomy
  • Lymph Node Excision
  • Sentinel Lymph Node Biopsy
  • Uterine Neoplasms
  • Chemotherapy, Adjuvant
  • Endometrial Neoplasms

Dr. Mastroyannis' most frequent co-authors

Recent publications by Dr. Mastroyannis

See all 25 publications and co-authors

See who Dr. Mastroyannis researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mastroyannis works with, so you can find a warm path to the right gynecologic oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Spyridon A. Mastroyannis received $100 in industry payments from 2023 to 2025

CMS Open Payments shows 3 general payments to Dr. Mastroyannis from 3 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Caris MPI, Inc. paid the most, $43.

General payments to Dr. Mastroyannis by program year, 2023 to 2025

Companies that paid Dr. Mastroyannis the most, 2023 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Mastroyannis

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Spyridon A. Mastroyannis graduated from George Washington University School of Medicine

Dr. Mastroyannis graduated from George Washington University School of Medicine in 2015.

  1. Medical schoolGeorge Washington University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Spyridon A. Mastroyannis's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Spyridon A. Mastroyannis

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Spyridon A. Mastroyannis' NPI number?

Dr. Spyridon A. Mastroyannis' NPI number is 1700272986. It was assigned on April 14, 2015, and it is active in the NPI Registry.

What kind of doctor is Dr. Spyridon A. Mastroyannis?

Dr. Spyridon A. Mastroyannis is a gynecologic oncologist in Loveland, Colorado. The primary specialty in the NPI Registry is Gynecologic Oncology Physician (taxonomy code 207VX0201X).

Where does Dr. Spyridon A. Mastroyannis practice?

Dr. Mastroyannis practices at 2695 Rocky Mountain Ave, Loveland, CO 80538. Dr. Mastroyannis' primary practice is UCHealth Medical Group in Loveland, Colorado. Dmand AI also links Dr. Mastroyannis to 5 hospitals, 1 group practice or clinic and 1 medical group.

What is Dr. Spyridon A. Mastroyannis' office phone number?

The practice phone on file for Dr. Mastroyannis is (970) 203-7050.

What is Dr. Spyridon A. Mastroyannis' medical license number?

Dr. Mastroyannis holds Colorado license DR.0068092.

Which hospitals is Dr. Spyridon A. Mastroyannis affiliated with?

Dr. Mastroyannis is affiliated with UCHealth Medical Center of the Rockies. Dmand AI links Dr. Mastroyannis to 5 more hospitals.

What medical group is Dr. Spyridon A. Mastroyannis part of?

Dr. Mastroyannis is linked to University of Colorado Medicine (CU Medicine). Dmand AI links Dr. Mastroyannis to 1 more medical group.

Does Dr. Spyridon A. Mastroyannis accept Medicare?

Yes. CMS data shows Dr. Mastroyannis billed Medicare for 229 services in 2024, and Dr. Mastroyannis accepts Medicare assignment.

Does Dr. Spyridon A. Mastroyannis offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Mastroyannis as offering telehealth services.

How many Medicare patients does Dr. Spyridon A. Mastroyannis see?

CMS counts 115 Medicare patients who saw Dr. Mastroyannis in 2024, with an average age of 73.

Show 7 more questionsShow fewer questions

What services does Dr. Spyridon A. Mastroyannis bill to Medicare?

In 2024, Dr. Mastroyannis' most billed Medicare services were office visit, new patient (99205), office visit, established patient (99215) and medicare service (G2211).

Where did Dr. Spyridon A. Mastroyannis go to medical school?

Dr. Mastroyannis graduated from George Washington University School of Medicine in 2015.

What drugs does Dr. Spyridon A. Mastroyannis prescribe most?

In 2024 Medicare Part D data, Dr. Mastroyannis' most prescribed drugs by claims were Eliquis and Imiquimod.

Has Dr. Spyridon A. Mastroyannis received payments from drug or device companies?

CMS Open Payments shows $100 in general payments to Dr. Mastroyannis from 3 companies from 2023 to 2025. The largest total came from Caris MPI, Inc.

How long has Dr. Spyridon A. Mastroyannis been practicing?

Dr. Mastroyannis graduated from medical school in 2015, 11 years ago.

Does Dr. Spyridon A. Mastroyannis do research?

Dmand AI links 25 publications to Dr. Mastroyannis, published from 2013 to 2025.

Who does Dr. Spyridon A. Mastroyannis publish with?

Dr. Mastroyannis' most frequent co-authors are Dimitrios Nasioudis, MD (12 shared papers), Emily M. Ko, MD (11 shared papers) and Lori Amanda Cory, MD (3 shared papers).

Selling to gynecologic oncology practices?

See gynecologic oncologists in Colorado by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)